Zion Market Research Global Cancer Tumor Profiling Market, 2016–2024 | Page 3

Cancer/Tumor Profiling Market
tests and personalized medicine in cancer/tumor profiling are anticipated to provide a broad
range of growth opportunities for the players market.
Global Cancer/Tumor Profiling Market: Segmentation
Global cancer/tumor profiling market can be segmented on the basis of application,
technology, technique, and region. The application segment of the market can be divided
into diagnostics, personalized medicine, prognostics, biomarker discovery, and research
applications. The technology segment of the market is classified into in-situ hybridization,
quantitative polymerase chain reaction, next-generation sequencing, and
immunohistochemistry. The technique segment of cancer/tumor profiling market is
diversified into metabolomics, genomics, epigenetics, and proteomics. Regionally, the global
market is grouped into North America, Europe, Asia-Pacific, Latin America, and the Middle
East & Africa.
Request Report TOC (Table of Contents) @
https://www.zionmarketresearch.com/toc/cancer-tumor-profiling-market
Global Cancer/Tumor Profiling Market: Regional Analysis
North America and Europe are expected to dominate the market for global cancer/tumor
profiling in the coming period. The growth of these regions can be attributed to factors such
as increasing prevalence of patients suffering from cancer, encouraging government plans
that are concentrated toward appropriate diagnosing and screening, the existence of a huge
number of technology suppliers, and accessibility of enhanced research & development.
Asia Pacific region is also anticipated to boost the market in the near future owing to the
better buying power of patients, increasing frequency of cancer, and economic